When I started in web development, everything was hard-coded—Content Management Systems (CMSs) didn’t exist. The ease of quick content updates that editors enjoy today was something we could only dream of back then. Ironically, this made things simpler. Then came the era of the CMS, which promised to make things easier but, in reality, offered some fairly horrendous options to work with.
Posted on
When approaching the design and build of websites and digital products within the corporate B2B world, investing in a solid UX strategy is often marginalised, viewed as a “nice-to-have” that time and budget may not allow. While UX should lead every project, deeper research and audits often get squeezed into early discovery phases – offering guidance but limited by tight timelines, budget constraints, and an underappreciation of UX benefits.
Posted on
Building on our recent success in the Digital Impact Awards, we’re thrilled to announce that all three of our entries have made the shortlist for this year’s Corporate & Financial Awards.
Posted on
We're super excited that all five of our 2024 Digital Impact Awards entries have made it to the final shortlist, with the winners being revealed at the awards ceremony on October 15!
Posted on
Umbraco 8 will reach its end-of-life (EOL) on February 24, 2025, signalling the end of official updates and support for version 8. This should come as no surprise! As with any well-managed product and software EOL programme, the deadline has been public for some time – we all knew it was coming but now the clock is ticking and decisions need to be made.
Posted on
We are delighted to have supported the team at Rosebank Industries in their recent pre- and post-IPO activities and successful admission to the AIM market.
Posted on
We’re excited to be launching a new brand and website for NomadX — the next step in the evolution of pioneering diagnostics.
Posted on
Zealand Pharmaceutical are a leading purpose-led biotechnology company, driven by the desire to change lives with next-generation peptide therapeutics.
Posted on
